TheStreet home
TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Mark Messier

Articles From This Author

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

The Run-Up Trade: Biodel's Insulin Trial Results

Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS

Rockwell Medical Run-Up Trade Follows Financing

FDA Tells Delcath No Approval Without New Clinical Trial
STOCKS

Synta Is Run-Up to ASCO Lung Cancer Data

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

Expecting Ziopharm Shares To Run Into Phase III Data At Month's End

Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS

Run-Up Trade Into Dynavax's FDA Approval Decision

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

Titan Pharma: Run-Up Trade Into March FDA Panel

Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

A.P. Pharma Run-Up Trade Into FDA Approval Decision

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Shorting Alexza Pharma On FDA's Adasuve Approval

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

Anacor Pharma: Run-Up Trade Into January Trial Data

One Short Seller's Take On Arena's Slow Belviq Launch
STOCKS

Hyperion Shares Poised to Run Up Ahead of FDA Decision

FDA Tells Delcath No Approval Without New Clinical Trial
STOCKS

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Celsion: Run-Up Trade Into Thermodox Results

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

Short Trade: Supernus IPO Lock-Up

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

How to Prep for the Inevitable Bursting of the Biotech Stock Bubble

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

How to Trade Hemispherx Even If You Hate the Stock

Spectrum Pharma Implodes On Colossal Fusilev Sales Warning
STOCKS

Zogenix: Three Shots At Run-Up Trade

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Dynavax: The BioRunUp Trade Into An FDA Panel